Scott Anderson, | |
464 S Saint Joseph Ave Ste 100, Arcadia, WI 54612-1401 | |
(608) 323-9998 | |
(608) 323-2150 |
Full Name | Scott Anderson |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 464 S Saint Joseph Ave Ste 100, Arcadia, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043767296 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 2343-19 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Scott Anderson, 464 S Saint Joseph Ave Ste 100, Arcadia, WI 54612-1401 Ph: (608) 323-9998 | Scott Anderson, 464 S Saint Joseph Ave Ste 100, Arcadia, WI 54612-1401 Ph: (608) 323-9998 |
News Archive
Aperion Biologics, Inc. was granted the CE Mark approval for its lead product, the Z-Lig ACLR device, to be used by surgeons in the European Union and other territories that accept the CE Mark.
The U. S. Patent and Trademark Office recently issued a patent to the U. S. Department of Health and Human Services involving resiniferatoxin, or RTX, an experimental compound that represents a potential new class of drugs to alleviate the intractable pain that can occur in people with advanced cancer, severe arthritis, and other extremely chronic conditions.
International research into the relationship between obesity and heart failure has uncovered a bleak outlook for already overweight Australians. The research shows that obesity is set to be one of the biggest risks for heart disease over the next decade.
The New York Times: Study Finds Criminal Pasts Of Nursing Home Workers.
› Verified 8 days ago